Cytogenetic studies of infant acute lymphoblastic leukemia: Poor prognosis of infants with t(4;11) - A report of the Children's Cancer Group

Leukemia

Volumn 13, Issue 5, 1999, Pages 679-686

  Heerema, N A ^a,g   Sather, H N ^b   Ge, J ^b   Arthur, D C ^c   Hilden, J M ^d   Trigg, M E ^e   Reaman, G H ^f  

^a PARKER HUGHES INSTITUTE   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d CHILDREN S HOSPITALS AND CLINICS OF MINNESOTA   (United States)

^e DUPONT COMPANY   (United States)

^f GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^g CHILDREN S ONCOLOGY GROUP   (United States)

Author keywords

Acute lymphoblastic leukemia; Chromosome 11q23; Infant leukemia; t(4:11)(q21; q23)

Indexed keywords

ASPARAGINASE; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYTARABINE; DAUNORUBICIN; FOLINIC ACID; MERCAPTOPURINE; METHOTREXATE; PREDNISONE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; AGE; ARTICLE; CANCER SURVIVAL; CHILDHOOD LEUKEMIA; CHROMOSOME 11Q; CHROMOSOME BREAKAGE; CHROMOSOME REARRANGEMENT; CORRELATION FUNCTION; CYTOGENETICS; FEMALE; HUMAN; HUMAN CELL; INFANT; INTRATHECAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; KARYOTYPE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; REMISSION;

EID: 0032980445     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401413     Document Type: Article

References (42)

1. Heerema NA, Arthur DC, Sather H, Albo V, Feusner J, Lange BJ, Steinherz PG, Zeltzer P, Hammond D, Reaman GH. Cytogenetic features of infants less than 12 months of age at diagnosis of acute lymphoblastic leukemia: impact of the 11q23 breakpoint on outcome: a report of the Childrens Cancer Group. Blood 1994; 83: 2274-2284.
2. Hilden JM, Frestedt JL, Moore RO, Heerema NA, Arthur DC, Reaman GH, Kersey JH. Molecular analysis of infant acute lymphoblastic leukemia: MLL gene rearrangement and reverse transcriptase-polymerase chain reaction for t(4;11)(q21;q23). Blood 1995; 86: 3876-3882.
3. Pui C, Ribeiro RC, Campana D, Raimondi SC, Hancock ML, Behm FG, Sandlund JT, Rivera GK, Evans WE, Crist WM, Krance R. Prognostic factors in the acute lymphoid and myeloid leukemias of infants. Leukemia 1996; 10: 952-956.
4. Chen C-S, Sorensen PHB, Domer PH, Reaman GH, Korsmeyer SJ, Heerema NA, Hammond GD, Kersey JH. Molecular rearrangements on chromosome 11q23 predominate in infant acute lymphoblastic leukemia and are associated with specific biologic variables and poor outcome. Blood 1993; 81: 2386-2393.
5. Pui C, Kane JR, Crist WM. Biology and treatment of infant leukemias (review). Leukemia 1995; 9: 762-769.
6. Rubnitz JE, Link MP, Shuster JJ, Carroll AJ, Hakami N, Frankel LS, Pullen DJ, Cleary ML. Frequency and prognostic significance of HRX rearrangements in infant acute lymphoblastic leukemia: a Pediatric Oncology Group study. Blood 1994; 84: 570-573.
7. Martinez-Climent JA, Lane NJ, Rubin CM, Morgan E, Johnstone HS, Mick R, Murphy SB, Vardiman JW, Larson RA, Le Beau MM, Rowley JD. Clinical and prognostic significance of chromosomal abnormalities in childhood acute myeloid leukemia de novo. Leukemia 1995; 9: 95-101.
8. Taki T, Ida K, Hanada R, Kikuchi A, Yamamoto K, Sako M, Tsuchida M, Seto M, Ueda R, Hayashi Y. Frequency and clinical significance of the MLL gene rearrangements in infant acute leukemia. Leukemia 1996; 10: 1303-1307.
9. Cimino G, Rapanotti MC, Rivolta A, Lo Coco F, D'Arcangelo E, Rondelli R, Basso G, Barisone E, Rosanda C, Santostasi T, Canaani E, Masera G, Mandelli F, Biondi A. Prognostic relevance of ALL-1 gene rearrangement in infant acute leukemias. Leukemia 1995; 9: 391-395.
10. Martinez-Climent JA, Thirman MJ, Espinosa R III, Le Beau MM, Rowley JD. Detection of 11q23/MLL rearrangements in infant leukemias with fluorescence in situ hybridization and molecular analysis. Leukemia 1995; 9: 1299-1304.
11. Cimino G, Lo Coco F, Biondi A, Elia L, Luciano A, Croce CM, Masera G, Mandelli F, Canaani E. ALL-1 gene at chromosome 11q23 is consistently altered in acute leukemia of early infancy. Blood 1993; 82: 544-546.
12. Behm FG, Raimondi SC, Frestedt JL, Liu Q, Crist WM, Downing JR, Rivera GK, Kersey JH, Pui CH. Rearrangement of the MLL gene confers a poor prognosis in childhood acute lymphoblastic leukemia, regardless of presenting age. Blood 1996; 87: 2870-2877.
13. Reaman GH, Sposto R, Sensel MG, Lange BJ, Feusner JH, Heerema NA, Leonard M, Holmes EJ, Sather HN, Pendergrass TW, Johnstone HS, O'Brien JP, Steinherz PG, Zeltzer PM, Gaynon PS, Trigg ME, Uckun FM. Treatment outcome and prognostic factors for infants with acute lymphoblastic leukemia treated on two consecutive trials of the Children's Cancer Group. J Clin Oncol 1999; 17: 445-455.
14. Second International Workshop on Chromosomes in Leukemia (1979). Cancer Genet Cytogenet 1980; 2: 89-113.
15. ISCN (1995). An International System for Human Cytogenetic Nomenclature. Mitelman F (ed). S Karger: Basel, 1995.
16. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
17. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966; 50: 163-170.
18. Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV, Mantel N, McPherson K, Peto J, Smith PG. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II, Analysis and examples. Br J Cancer 1977; 35: 1-35.
19. Breslow N. Comparison of survival curves. In: Buyse M, Staquet M, Sylvester R (eds). Cancer Clinical Trials: Methods and Practice. Oxford University Press: Oxford, 1988, pp 381-406.
20. Cox DR. Regression models and life-tables (with discussion). JR Stat Soc, Ser B 1972; 34: 187-220.
21. Breslow NE. Analysis of survival data under the proportional hazards model. Int Stat Rev 1975; 43: 45-58.
22. Rubnitz JE, Behm FG, Downing JR. 11q23 rearrangements in acute leukemia. Leukemia 1996; 10: 74-82.
23. Cimino G, Nakamura T, Gu Y, Canaani O, Prasad R, Crist WM, Carroll AJ, Baer M, Bloomfield CD, Nowell PC, Croce CM, Canaani E. An altered 11-kilobase transcript in leukemic cell lines with the t(4;11)(q21;q23) chromosome translocation. Cancer Res 1992; 52: 3811-3813.
24. Cimino G, Moir DT, Canaani O, Williams K, Crist WM, Katzav S, Cannizzaro L, Lange B, Nowell PC, Croce CM, Canaani E. Cloning of ALL-1, the locus involved in leukemias with the t(4;11 )(q21;q23), t(9;11)(p22;q23), and t(11;19)(q23;p13) chromosome translocations. Cancer Res 1991; 51: 6712-6714.
25. Morrissey J, Tkachuk DC, Milatovich A, Francke U, Link M, Cleary ML. A serine/proline-rich protein is fused to HRX in t(4;11) acute leukemias. Blood 1993; 81: 1124-1131.
26. Nakamura T, Alder H, Gu Y, Prasad R, Canaani O, Kamada N, Gale RP, Lange B, Crist WM, Nowell PC, Croce CM, Canaani E. Genes on chromosome-4, chromosome-9, and chromosome-19 involved in 11q23 abnormalities in acute leukemia share sequence homology and/or common motifs. Proc Natl Acad Sci USA 1993; 90: 4631-4635.
27. Li Q, Frestedt JL, Kersey JH. AF4 encodes a ubiquitous protein that in both native and MLL-AF4 fusion types localizes to subnuclear compartments. Blood 1998; 92: 3841-3847.
28. Bernard OA, Berger R. Molecular basis of 11q23 rearrangements in hematopoietic malignant proliferations (review). Genes Chromosom Cancer 1995; 13: 75-85.
29. Hunger SP, Tkachuk DC, Amylon MD, Link MP, Carroll AJ, Welborn JL, Willman CL, Cleary ML. HRX involvement in de novo and secondary leukemias with diverse chromosome 11q23 abnormalities. Blood 1993; 81: 3197-3203.
30. Parkin JL, Arthur DC, Abramson CS, McKenna RW, Kersey JH, Heideman RL, Brunning RD. Acute leukemia associated with the t(4;11) chromosome rearrangement: ultrastructural and immunologic characteristics. Blood 1982; 60: 1321-1331.
31. Rubnitz JE, Behm FG, Curcio-Brint AM, Pinheiro VRP, Carroll AJ, Raimondi SC, Shurtleff SA, Downing JR. Molecular analysis of t(11;19) breakpoints in childhood acute leukemias. Blood 1996; 87: 4804-4808.
32. Prasad R, Gu Y, Alder H, Nakamura T, Canaani O, Saito H, Huebner K, Gale RP, Nowell PC, Kuriyama K, Miyazaki Y, Croce CV, Canaani E. Cloning of the ALL-1 fusion partner; the AF-6 gene, involved in acute myeloid leukemias with the t(6;11) chromosome translocation. Cancer Res 1993; 53: 5624-5628.
33. Iida S, Seto M, Yamamoto K, Komatsu H, Tojo A, Asano S, Kamada N, Ariyoshi Y, Takahashi T, Ueda R. MLLT3 gene on 9p22 involved in t(9;11) leukemia encodes a serine/proline rich protein homologous to MLLTI on 19p13. Oncogene 1993; 8: 3085-3092.
34. Brodeur GM. Molecular basis for heterogeneity in human neuroblastomas (review). Eur J Cancer 1995; 31A: 505-510.
35. Greaves MF. Infant leukaemia biology, aetiology and treatment. Workshop Report. Leukemia 1996; 10: 372-377.
36. Ross JA, Potter JD, Robison LL. Infant leukemia, topoisomerase II inhibitors, and the MLL gene. J Natl Cancer Inst 1994; 86: 1678-1680.
37. Ross JA, Davies SM, Potter JD, Robison LL. Epidemiology of childhood leukemia, with focus on infants. Epidemiol Rev 1994; 16: 243-272.
38. Gynon PS, Desai AA, Bostrom BC, Hutchinson RJ, Lange BJ, Nachman JB, Reaman GH, Sather HN, Steinherz PG, Trigg ME, Tubergen DG Uckun FM. Early response to therapy and outcome in childhood acute lymphoblastic leukemia. A review. Cancer 1997; 80: 1717-1726.
39. Uckun FM, Nachman JB, Sather HN, Sensel MG, Kraft P, Steinherz PG, Lange B, Hutchinson R, Reaman GH, Gaynon PS, Heerema NA. Clinical significance of Philadelphia chromosome-positive pediatric acute lymphoblastic leukemia in the context of contemporary intensive therapies: a report from the Children's Cancer Group. Cancer 1998; 83: 2030-2039.
40. Gibbons B, Katz FE, Ganly P, Chessells JM. Infant acute lymphoblastic leukaemia with t(11;19). Br J Haematol 1990; 74: 264-269.
41. Huret JL, Brizard A, Slater R, Charrin C, Bertheas MF, Guilhot F, Hählen K, Kroes W, van Leeuwen E, Schoot EVD, Beishuizen A, Tanzer J, Hagemeijer A. Cytogenetic heterogeneity in t(11;19) acute leukemia: clinical, hematological and cytogenetic analyses of 48 patients - updated published cases and 16 new observations. Leukemia 1993; 7: 152-160.
42. Raimondi SC, Frestedt JL, Pui C, Downing JR, Head DR, Kersey JH, Behm FG. Acute lymphoblastic leukemias with deletion of 11q23 or a novel inversion (11)(p13q23) lack MLL gene rearrangements and have favorable clinical features. Blood 1995; 86: 1881-1886.